Responses
Regular and Young Investigator Award Abstracts
Clinical Trial In Progress
718 Phase 1/2 study of PRO1160, a CD70-directed antibody-drug conjugate, in patients with advanced solid tumors and hematologic malignancies
Compose a Response to This Article
Other responses
No responses have been published for this article.
